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Hypertension is an important risk factor of atherosclerosis \[[@B1]-[@B3]\] and stroke \[[@B4],[@B5]\]. There are more evidences showing that carotid atherosclerosis increases risk of ischemic stroke \[[@B6],[@B7]\]. It is possible that carotid atherosclerosis could be one of the causal links between hypertension and ischemic stroke. For the past decades, several prospective studies indicates that a systolic/diastolic blood pressure above 115/75 mmHg is associated with increased risk of stroke \[[@B8]\], suggesting that the blood pressure status proceeding from normal to hypertension is a risk factor of stroke. The potential mechanism of this association is still unclear. Several studies have reported the blood pressure level from 120/80 mmHg to 139/89 mmHg is correlated with multiple vascular risk factors \[[@B9]-[@B11]\]. We assumed that the blood pressure status proceeding from normal to hypertension could cause carotid atherosclerosis. However, this hypothesis has not been proved, especially in Chinese population. Whether the normal blood pressure (BP) is associated with the same severity of carotid atherosclerosis as hypertension in Chinese population or not needs to be investigated. Furthermore, it is interesting to define the blood pressure level, which can stratify risk of carotid atherosclerosis in Chinese population.

In this study, we investigated the association of carotid atherosclerotic plaque formation and blood pressure level from normal (120/80 mmHg) to hypertension (140/90 mmHg) in middle aged and elderly community population in Southern China.

Methods
=======

Study cohort
------------

Study participants were enrolled from community populations in Guangzhou, China. Participants were enrolled by the Department of Neurology, the First Affiliated Hospital of Sun Yat-sen University from July 2008 to December 2008. Those who are aged from 46 to 75 with Chinese ethnic were eligible for the study. Those who had cardiovascular diseases more than six months ago and totally recovered without any persistent symptoms, sequelae or disabilities were not excluded in the study. However, those who had malignant tumors, acute or sub-acute symptomatic cardiovascular diseases (the period between the recovery from the diseases and the study recruitment was less than six months), and other critical illnesses were excluded. People who refused to complete necessary questionnaires were also excluded. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University, and all participants agreed on the written informed consent of the study.

Medical risk factors and cigarette/alcohol intake
-------------------------------------------------

Previous histories of hypertension, diabetes, heart disease or stroke were defined if the subjects had been diagnosed with the disease in hospital before or had used medications regularly. Cigarette smoking was defined if the subjects had smoked more than one cigarette per day for more than half a year. Alcohol intake was defined if the subjects had alcohol consumption more than once a week for more than half a year.

Physical and biological risk factors
------------------------------------

Waist and hip circumference, weight and height were measured and waist-hip ratio (WHR) was calculated. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m^2^). Blood pressure was measured at least twice with a mercury sphygmomanometer after the participants had rested for no less than ten minutes in seat, and all measurements of the blood pressure were performed at the same time period in the morning by one well-trained investigator. If the two readings were different from each other for over 5 mmHg, a third measurement was performed after the participants had more rest in seat. The blood pressure of each participant was calculated as the average of the readings.

Blood samples for fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were collected in the morning and then analyzed by the enzyme method in auto-analyzing machine. The coefficients of variance (CVs) of repeated measurements were 1.0% to 1.6%.

According to the definition of World Health Organization (WHO) in 1999 \[[@B12]\], central obesity, also called abdominal obesity, was defined as waist-to-hip ratio (WHR) \> 0.90 for Chinese males or WHR \> 0.85 for Chinese females. Participants with different levels of blood pressure were divided into several groups based on two main classifications, JNC-7 and ESH/ESC system. According to the JNC-7 in 2003 \[[@B13]\], hypertension (HT) is defined if systolic blood pressure (SBP) is ≥ 140 mmHg, diastolic blood pressure (DBP) is ≥ 90 mmHg, or if the patients have been diagnosed or had taken antihypertensive drugs ever before. Prehypertension (Pre-HT) is defined if the patients have not been diagnosed, or have not taken antihypertensive drugs and have a SBP between 120 to 139 mmHg and/or DBP between 80 to 89 mmHg. Normotension (NT) is defined if one has not been diagnosed, has not taken antihypertensive drugs before and has a SBP \< 120 mmHg and DBP \< 80 mmHg. According to the ESH/ESC in 2007 \[[@B14]\], hypertension and optimal blood pressure is defined the same as the hypertension and normotension in JNC-7, respectively. The normal BP is further divided into two groups; high normal BP, which has a SBP between 130 to 139 mmHg and/or DBP between 85 to 89 mmHg, and normal BP, which had a SBP between 120 to 129 mmHg and/or DBP between 80 to 84 mmHg.

Ultrasound measurements of carotid IMT and plaques
--------------------------------------------------

Carotid ultrasound measurements were performed with two B-mode ultrasound systems; APLIO XU equipped with a 7.5 MHz linear array transducer (Toshiba, USA) and HDI 5000 with a 5 \~ 12 MHz linear array transducer (Philips, USA). Subjects were examined in supine position with their necks extended. Measurements were taken in the diastolic phase in a proper direction for best visualization of the arteries. Intima-media thickness (IMT) was measured as the distance between the two parallel echogenic lines on the far wall of artery in longitudinal plane image frozen in the screen by electronic calipers \[[@B6]\]. IMT in three defined locations were measured bilaterally: common carotid (20 mm proximal to the bifurcation), carotid bifurcation and internal carotid (10 mm distal to bifurcation) (Figure [1](#F1){ref-type="fig"}). Mean IMT was calculated as the average of the six readings of bilateral carotid arteries. Plaque was defined as localized thickening of IMT ≥ 1.3 mm which did not uniformly involve the whole wall of carotid artery \[[@B1],[@B15]\]. Quality controls were made by repeated scans on several randomly selected participants who were examined twice by two sonographers. The coefficient of variance (CV) of the mean IMT was 10.3%. The inter-observer difference was 0.08 ± 0.08 and the correlation of two readings was 0.661 (*p \<* 0.001). The agreement of plaque occurrence was 88.1% and the kappa value was 0.738 (*p \<* 0.001).

![**The measurement of carotid IMT.**The point of carotid bifurcation is defined as the point (**b**). And the points of CCA and ICA are measured at point (**a**) and (**c**). Mean cIMT is calculated as the average cIMT of points **a** + **b** + **c**.](1471-2261-13-20-1){#F1}

Statistical methods
-------------------

Continuous variables were described as unadjusted means ± standard deviations (SD) or means ± standard errors (SE) when the means were adjusted for age and/or sex. Dichotomized or categorized variables were described as numbers and unadjusted proportions. In the univariate analysis, unadjusted means were compared by student's t-tests if the means were from two groups or by one-way ANOVA if the means were from more than two groups. In the multivariate analysis, adjusted means were compared by ANCOVA with different variables adjusted. Dichotomized or categorized variables were compared by Chi-square tests, and multivariate logistic regression was used for comparing different proportions when adjusting age, sex and other risk factors. Odds ratios (OR) were calculated by logistic model. All statistic analysis was calculated with SPSS 13.0 software system. A two-sided p-value of less than 0.05 was considered as statistically significant.

Results
=======

Analysis of study cohort
------------------------

Among 1025 residents who participated in our study, 942 residents completed all examinations and were included in the analysis. The 942 participants aged 57.2 ± 5.9 years old on average, which come from several provinces of Southern China, and they had lived and worked in Guangzhou for 45.1 ± 13.9 years on average. Of all the study population, 932 (98.9%) were the *Han* nationality. The proportion of previously diagnosed hypertension and diabetes mellitus in the study population was 28.0% and 9.6%, respectively, which were comparable with that in other randomized studies of Chinese population \[[@B16],[@B17]\].

Among total 392 hypertensive participants, 234 (59.7%) had antihypertensive medicine daily, while the others had not taken antihypertensive drugs before because they were newly diagnosed (Table [1](#T1){ref-type="table"}). Blood pressure of 309 residents fit in prehypertension group according to JNC-7 criteria. 241 residents have normotension blood pressure. None of residents in these two groups had taken antihypertensive medicine before. 66 (7.0%) participants had taken daily antidiabetic drugs and 42 (4.5%) participants had taken lipid-lowering medication (Table [1](#T1){ref-type="table"}). Prehypertensive residents were further divided into 191 residents with normal BP and 118 residents with high normal BP according to ESH/ESC criteria (Table [2](#T2){ref-type="table"}).

###### 

Metabolic factors and carotid atherosclerosis in different blood pressure levels according to JNC-7

                                   **Normotension**   **Prehypertension**   **Hypertension**   ***P*for trend**
  ------------------------------- ------------------ --------------------- ------------------ ------------------
  N                                      241                  309                 392              \-\-\--
  Male/female                           54/187            106/203 \#           149/243 \#          \<0.001
  Age, years                         55.5 ± 5.0 §       56.4 ± 5.5 \#§       58.9 ± 6.2 \#         \<0.001
  WC, cm                             77.1 ± 7.9 §       82.4 ± 8.5 \#§       85.4 ± 9.1 \#         \<0.001
  WHR                               0.85 ± 0.06 §       0.88 ± 0.07 \#§      0.90 ± 0.07 \#        \<0.001
  BMI, kg/m^2^                       21.8 ± 3.0 §       23.5 ± 3.1 \#§       24.6 ± 3.3 \#         \<0.001
  SBP, mmHg                         107.4 ± 7.8 §       124.2 ± 6.4 \#§     140.7 ± 15.2 \#        \<0.001
  DBP, mmHg                          69.2 ± 5.7 §       78.5 ± 5.4 \#§       86.5 ± 10.3 \#        \<0.001
  PP, mmHg                           38.3 ± 7.1 §       45.7 ± 8.1 \#§       54.2 ± 13.6 \#        \<0.001
  FBG, mmol/L                        5.0 ± 1.1 §          5.1 ± 0.9 §         5.4 ± 1.4 \#          0.001
  TC, mmol/L                         5.19 ± 0.96          5.28 ± 0.97         5.25 ± 1.00           0.487
  TG, mmol/L                        1.41 ± 0.78 §       1.74 ± 1.10 \#       1.98 ± 2.06 \#        \<0.001
  LDL-C, mmol/L                      3.53 ± 0.84          3.61 ± 0.88         3.65 ± 0.93           0.089
  HDL-C, mmol/L                     1.49 ± 0.34 §       1.39 ± 0.36 \#§      1.31 ± 0.32 \#        \<0.001
  DM, n (%)                           13 (5.4) §          23 (7.4) §          54 (13.8) \#         \<0.001
  CHD, n (%)                           4 (1.7)             8 (2.6) §          38 (9.7) \#          \<0.001
  IS, n (%)                            0 (0.0)              4 (1.3)           14 (3.6) \#           0.001
  Smokers, n (%)                     32 (13.3) §           59 (19.1)          82 (20.9) \#          0.020
  Alcohol, n (%)                       13 (5.4)            25 (8.1)             32 (8.2)            0.230
  WHO CO, n (%)                      97 (40.2) §        179 (57.9) \#§       275 (70.2) \#         \<0.001
  Antihypertensive drugs, n (%)        0 (0.0)             0 (0.0) §         234 (59.7) \#         \<0.001
  Antidiabetic drugs, n (%)            11 (4.6)           17 (5.5) §          38 (9.7) \#           0.022
  Lipid-lowering drugs, n (%)          5 (2.1%)            5 (1.6) §          32 (8.2) \#          \<0.001

*BP*, blood pressure; *WC*, waist circumference; *WHR*, waist-to-hip ratio; *BMI*, body mass index; *SBP*, systolic blood pressure; *DBP*, diastolic blood pressure; *PP*, pulse pressure; *FBG*, fasting blood glucose; *TC*, total cholesterol; *TG*, triglyceride; *LDL-C*, low-density lipoprotein cholesterol; *HDL-C*, high-density lipoprotein cholesterol; *DM*, diabetes mellitus; *CHD*, coronary heart diseases; *IS*, ischemic stroke; *WHO CO*, central obesity of WHO criteria; Values are unadjusted mean ± SD or number (%). P values are compared among the three/four groups by one-way ANOVA or *χ*^2^tests.

\# versus Normotension, *p* \< 0.05; § versus Hypertension, *p* \< 0.05.

###### 

Metabolic factors and carotid atherosclerosis in the population with normal BP and high normal BP according to ESH/ESC-2007

                                   **Normal BP**   **High normal BP**   ***P*values**
  ------------------------------- --------------- -------------------- ---------------
  N                                     191               118              \-\-\--
  Male/female                         57/134             49/69              0.036
  Age, years                        56.1 ± 5.2         56.9 ± 5.8           0.042
  WC, cm                            81.5 ± 8.5         83.9 ± 8.5           0.938
  WHR                               0.88 ± 0.07       0.89 ± 0.06           0.575
  BMI, kg/m^2^                      23.2 ± 3.1         24.0 ± 2.9           0.568
  SBP, mmHg                         120.8 ± 4.2       129.7 ± 5.5           0.457
  DBP, mmHg                         77.2 ± 4.8         80.7 ± 5.6           0.386
  PP, mmHg                          43.7 ± 6.9         49.0 ± 8.8           0.121
  FBG, mmol/L                        5.1 ± 0.9         5.1 ± 0.9            0.597
  TC, mmol/L                        5.22 ± 0.97       5.38 ± 0.98           0.809
  TG, mmol/L                        1.70 ± 1.09       1.81 ± 1.12           0.930
  LDL-C, mmol/L                     3.60 ± 0.90       3.63 ± 0.84           0.793
  HDL-C, mmol/L                     1.40 ± 0.39       1.38 ± 0.31           0.362
  DM, n (%)                          12 (6.3)           11 (9.3)            0.323
  CHD, n (%)                          5 (2.6)           3 (2.5)             0.968
  IS, n (%)                           2 (1.0)           2 (1.7)             0.625
  Smokers, n (%)                     38 (19.9)         21 (17.8)            0.648
  Alcohol, n (%)                     16 (8.4)           9 (7.6)             0.814
  WHO CO, n (%)                     102 (53.2)         77 (65.3)            0.040
  Antihypertensive drugs, n (%)       0 (0.0)           0 (0.0)            \-\-\--
  Antidiabetic drugs, n (%)          10 (5.2)           7 (5.9)             0.794
  Lipid-lowing drugs, n (%)          4 (2.1%)           1 (0.8)             0.399
  IMTmean, mm                       0.76 ± 0.13       0.77 ± 0.14           0.596
  Plaque (+), n (%)                  43 (22.5)         34 (28.8)            0.213

*BP*, blood pressure; *WC*, waist circumference; *WHR*, waist-to-hip ratio; *BMI*, body mass index; *SBP*, systolic blood pressure; *DBP*, diastolic blood pressure; *PP*, pulse pressure; *FBG*, fasting blood glucose; *TC*, total cholesterol; *TG*, triglyceride; *LDL-C*, low-density lipoprotein cholesterol; *HDL-C*, high-density lipoprotein cholesterol; *DM*, diabetes mellitus; *CHD*, coronary heart diseases; *IS*, ischemic stroke; *WHO CO*, central obesity of WHO criteria; *IMTmean*, mean intima-media thickness of bilateral carotid arteries.

Values are unadjusted mean ± SD or number (percent). P values are compared between the two groups by student's T-tests or *χ*^2^ tests.

Metabolic factors and carotid atherosclerosis in different levels of blood pressure
-----------------------------------------------------------------------------------

Metabolic factors and carotid atherosclerosis in different levels of blood pressure according to JNC-7 and ESH/ESC classification were shown in Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}, respectively. In both classifications, age, WC, WHR, BMI, SBP, DBP, PP, TG, FBG, the diabetes mellitus rates, coronary heart disease rates, ischemic stroke rates and cigarette smoker rates linearly increased from low BP subgroups to higher BP subgroups in both females and males (*p \<* 0.05 for trend), while the levels of HDL-C had the reverse trend in both female and male (*p \<* 0.05 for trend) (Table [1](#T1){ref-type="table"}). The levels of TC and LDL-C and the alcohol intake rates did not have any significant changes in the BP subgroups in both female and male (*p \>* 0.05) (Table [1](#T1){ref-type="table"}).

In the JNC-7 classification, prehypertensive and hypertensive residents accompanied with higher prevalence of central obesity than normotensive ones (57.9% and 70.2% vs. 40.2%, both *p \<* 0.001) (Table [1](#T1){ref-type="table"}). Pre-HT and HT had not only thicker mean cIMT in carotid arteries than normotensive ones (0.76 ± 0.13 mm and 0.83 ± 0.15 mm vs. 0.71 ± 0.11 mm, both *p \<* 0.001) (Figure [2](#F2){ref-type="fig"}A), but also more occurrence of carotid plaque than normotensive ones (24.9% and 26.3% vs. 10.8%, *p \<* 0.001) (Figure [2](#F2){ref-type="fig"}B), suggesting that both Pre-HT and HT are associated with cIMT augment and carotid plaque formation. In the participants who had never had antihypertensive medication, cIMT was positively associated with systolic and diastolic blood pressure (Figure [3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B). Hypertensive residents had more prevalence of central obesity and had thicker mean cIMT than prehypertensive ones (*p =* 0.001 and *p \<* 0.001) (Figure [2](#F2){ref-type="fig"}A). However, there was no difference in carotid plaque occurrence between hypertensive and prehypertensive residents (*p =* 0.683) (Figure [2](#F2){ref-type="fig"}B).

![**Carotid IMT augment and the percentage of plaque formation in residents with normotension, prehypertesion, and hypertension in term of JNC-7 classification.**The blood pressures were divided into normotension, prehypertension, and hypertension groups. cIMT represents mean intima-media thickness of bilateral carotid arteries. \*\* versus normotension, *p* \< 0.001 **A**. Mean carotid IMT (cIMT) in residents with normotension, prehypertesion, and hypertension in term of JNC-7 classification. **B**. Carotid plaque formation in residents with normotension, prehypertesion, and hypertension in term of JNC-7 classification.](1471-2261-13-20-2){#F2}

![**Scatterplot of carotid IMT vs. systolic blood pressure (A) and diastolic blood pressure (B).**Antihypertensive drugs were never used or daily used in patient.](1471-2261-13-20-3){#F3}

In the ESH/ESC classification (Table [2](#T2){ref-type="table"}), residents with high normal BP had higher central obesity ratio than those with normal BP (*p =* 0.040). However, there was no difference in mean cIMT and plaque occurrence between normal BP and high normal BP (*p =* 0.681 and *p =* 0.213) (Table [2](#T2){ref-type="table"}).

Independent effect of prehypertension on carotid atherosclerosis
----------------------------------------------------------------

Given that there was no difference in carotid atherosclerosis between normal BP and high normal BP, we used prehypertension for further evaluation. As adjusting age, TG, HDL-C, FBG/diabetes, WC/central obesity and smoking status, prehypertensive participants had significantly thicker cIMT (*p \<* 0.001) and more carotid plaque occurrence (*p \<* 0.001) than normotensive participants (Table [3](#T3){ref-type="table"}). Age, sex, hypertension, central obesity and smoking were independent determinants of thicker cIMT (Table [3](#T3){ref-type="table"}). Hypertensive participants had significantly thicker cIMT than normotensive ones (OR and its 95% CI: 2.33, 1.40-3.87, *p =* 0.001), but prehypertensive participants had a trend to be with thicker cIMT than normotensive ones (OR and its 95% CI: 1.65, 0.97-2.82, *p =* 0.067). Age, prehypertension, central obesity and smoking were independent determinants of carotid plaque formation (Table [3](#T3){ref-type="table"}). Prehypertensive participants had significantly more carotid plaque occurrence than normotensive ones (OR and its 95% CI: 2.36, 1.43-3.88, *p =* 0.001).

###### 

Determinants of thicker carotid IMT and carotid plaque formation in the Logistic regression model

      **Determinants**      **Thicker carotid IMT**   ***P*value**   **Carotid plaque formation**   ***P*value**
  ------------------------ ------------------------- -------------- ------------------------------ --------------
             Age               1.11 (1.07, 1.14)        \<0.001           1.10 (1.07, 1.13)           \<0.001
             Sex               1.86 (1.21, 2.86)         0.005                    NS                     NS
       Central obesity         1.62 (1.11, 2.37)         0.013            1.55 (1.08, 2.22)            0.017
           Smoking             1.99 (1.22, 3.24)         0.006            1.51 (1.02, 2.23)            0.040
    Blood pressure levels                                                                          
        Prehypertension        1.65 (0.97, 2.82)         0.067            2.36 (1.43, 3.88)            0.001
         Hypertension          2.33 (1.40, 3.87)         0.001            1.88 (1.15, 3.07)            0.012

Thicker carotid IMT: upper quintile value of IMT.

*IMT*, intima-media thickness; *OR*, odds ratio; *CI*, confidence interval; *NS*, non-significant.

Discussion
==========

Consistent with previous studies in other populations \[[@B2],[@B18]-[@B24]\], age and metabolic risk factors such as elevating blood pressure, body mass index, waist circumference, triglyceride, diabetes and heavy smoking in Chinese population positively correlated with carotid IMT and plaque (Table [3](#T3){ref-type="table"}). However, which level of blood pressure would be the cut-off point to stratify significant status of atherosclerosis is not known. In this study, we found that the blood pressure level proceeding from normal to hypertension had been associated with significant carotid atherosclerotic plaque formation, independent of other vascular risk factors. The carotid atherosclerotic plaque formation in prehypertension was as severe as that in hypertension (Figure [2](#F2){ref-type="fig"}). Moreover, there is no difference of the carotid atherosclerotic plaque formation between normal BP and high normal BP in ESH/ESC-2007 criteria (Table [2](#T2){ref-type="table"}), so prehypertension should be considered as the cut-off point to stratify the risk of carotid atherosclerosis which can cause ischemic stroke in middle-aged and elderly community population in Southern China. Prehypertensive residents never had antihypertensive medication before, thus the medication usage would not affect the association between carotid atherosclerotic plaque formation and blood pressure level proceeding from normal to hypertension.

Prehypertension and hypertension are associated with resemble risk of plaque occurrence after adjusting other metabolic risk factors in multivariate analysis (Table [3](#T3){ref-type="table"}). However, the odds ratio of the association of prehypertension was slightly attenuated after multiple risk factors adjusted, indicating that some other risk factors such as obesity, triglyceride and smoking had synergistic effects on carotid plaque occurrence \[[@B1],[@B23]\]. Consistent with previous hypothesis \[[@B1],[@B25],[@B26]\], IMT thickening and plaque formation in carotid arterie reflect different biological aspects of atherosclerosis. IMT thickening is mainly the result of hypertrophy of smooth muscles in the medial layer of carotid artery wall, while plaque formation is caused by pathological intimal thickening involving in the deposition of lipid. As a result, it has been hypothesized that IMT augment in the common carotid artery is strongly related to age and hypertension, while plaque formation or IMT in the carotid bulb or internal carotid artery is strongly related to hypercholesterolemia and smoking \[[@B1]\].

In recent years, several epidemiological studies have focused on the target-organ-damages in the blood pressure level which rises from 120/80 mmHg to 140/90 mmHg. Prehypertensive patients had been found to have higher CCA-IMT and larger left ventricular mass than their normotensive counterparts \[[@B27]\]. Here, we demonstrated similar findings in carotid IMT (Figure [2](#F2){ref-type="fig"}). We also found that prehypertensive residents had more occurrence of carotid plaque. Both normal BP and high normal BP had the same trends and there are no difference between these two subgroups. In previous report, Natali et al found that high normal BP, but not normal BP, was more accurate in identifying the linear trend of increasing metabolic risk factors, while prehypertension identified a dishomogeneous group of individuals \[[@B28]\]. The discordant results from Natali's group and our group could be caused by different study populations. The Natali's study was performed on a non-randomized sampled population who were free of hypertension, hyperlipidemia and diabetes mellitus, while our study was a cross-sectional analysis on a middle-aged and elderly Southern Chinese community population free of symptomatic cardiovascular diseases within 6 months. The underlying mechanism of the effect of prehypertension on the carotid atherosclerosis remains to be further determined.

Our data were collected from a community-based population who had lived and worked in Guangzhou for years. Of all the study population, the proportion of hypertension or diabetes mellitus in some age group of male and female was comparable with the randomized Chinese population in previous studies (Data not shown). It should be noted that our study population was not a randomized cohort and many community-based studies also encountered the same problem of non-randomized cohort. The study goal is to investigate the association among metabolic factors, carotid atherosclerosis and different blood pressure levels and would not be affected by non-randomized cohorts. In addition, the enough sample size and proper set of methodologies could make the analysis reliable (Table [1](#T1){ref-type="table"}).

Conclusions
===========

In summary, prehypertension had been associated with significant carotid atherosclerotic plaque formation, independent of other vascular risk factors in middle-aged and elderly population in Southern China. Prehypertension could stratify the risk of carotid atherosclerosis and cardiovascular diseases, which cause ischemic stroke in Southern China. Our results suggest that prehypertension would be a warning status of higher risk of cardiovascular diseases. The population with prehypertension should be carefully monitored and life style modifications should be adapted to control BP and prevent the cardiovascular diseases and strokes.
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